| Holly Tammens, CNM | |
|
915 N King St, Honolulu, HI 96817-4544 | |
| (808) 848-1438 | |
| Not Available |
| Full Name | Holly Tammens |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 915 N King St, Honolulu, Hawaii |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215320270 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 1763 (Hawaii) | Primary |
| Entity Name | Kalihi-palama Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457304966 PECOS PAC ID: 4284544842 Enrollment ID: O20040414001002 |
News Archive
"Up to a quarter of a million women and girls in Southeast Asia, mostly adolescents, are forced into prostitution each year and face violence and the prospect of contracting HIV/AIDS," researchers said on Wednesday in a report about criminal activity in Cambodia, Indonesia and Thailand, Reuters reports.
Vanderbilt researchers have been selected to receive a national grant as part of a push to gauge the coming impact of the Affordable Care Act (ACA).
The latest research reveals that many people are unaware of the signs and symptoms of bowel cancer and do not know how lifestyle factors can contribute to risk.
Amgen (NASDAQ: AMGN) today announced new detailed data from three Phase 3 studies that showed treatment with its novel investigational cholesterol-lowering medication, evolocumab (AMG 145), resulted in a statistically significant reduction of 55-66 percent in low-density lipoprotein cholesterol (LDL-C) compared to placebo in patients with high cholesterol.
DiagnoCure, Inc., a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, announced that the clinical utility of the PROGENSA(R) PCA3 test, developed and commercialized by its partner Gen-Probe, was confirmed in two large worldwide studies, conducted in a subset of patients in GlaxoSmithKline's REDUCE trial of dutasteride. The results demonstrate that PCA3 can help determine whether men suspected of having prostate cancer should undergo a repeat biopsy and can predict the risk of having an aggressive cancer.
› Verified 9 days ago
| Entity Name | Koolau Womens Health Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427082445 PECOS PAC ID: 4385679414 Enrollment ID: O20050928000332 |
News Archive
"Up to a quarter of a million women and girls in Southeast Asia, mostly adolescents, are forced into prostitution each year and face violence and the prospect of contracting HIV/AIDS," researchers said on Wednesday in a report about criminal activity in Cambodia, Indonesia and Thailand, Reuters reports.
Vanderbilt researchers have been selected to receive a national grant as part of a push to gauge the coming impact of the Affordable Care Act (ACA).
The latest research reveals that many people are unaware of the signs and symptoms of bowel cancer and do not know how lifestyle factors can contribute to risk.
Amgen (NASDAQ: AMGN) today announced new detailed data from three Phase 3 studies that showed treatment with its novel investigational cholesterol-lowering medication, evolocumab (AMG 145), resulted in a statistically significant reduction of 55-66 percent in low-density lipoprotein cholesterol (LDL-C) compared to placebo in patients with high cholesterol.
DiagnoCure, Inc., a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, announced that the clinical utility of the PROGENSA(R) PCA3 test, developed and commercialized by its partner Gen-Probe, was confirmed in two large worldwide studies, conducted in a subset of patients in GlaxoSmithKline's REDUCE trial of dutasteride. The results demonstrate that PCA3 can help determine whether men suspected of having prostate cancer should undergo a repeat biopsy and can predict the risk of having an aggressive cancer.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Holly Tammens, CNM 915 N King St, Honolulu, HI 96817-4544 Ph: (808) 848-1438 | Holly Tammens, CNM 915 N King St, Honolulu, HI 96817-4544 Ph: (808) 848-1438 |
News Archive
"Up to a quarter of a million women and girls in Southeast Asia, mostly adolescents, are forced into prostitution each year and face violence and the prospect of contracting HIV/AIDS," researchers said on Wednesday in a report about criminal activity in Cambodia, Indonesia and Thailand, Reuters reports.
Vanderbilt researchers have been selected to receive a national grant as part of a push to gauge the coming impact of the Affordable Care Act (ACA).
The latest research reveals that many people are unaware of the signs and symptoms of bowel cancer and do not know how lifestyle factors can contribute to risk.
Amgen (NASDAQ: AMGN) today announced new detailed data from three Phase 3 studies that showed treatment with its novel investigational cholesterol-lowering medication, evolocumab (AMG 145), resulted in a statistically significant reduction of 55-66 percent in low-density lipoprotein cholesterol (LDL-C) compared to placebo in patients with high cholesterol.
DiagnoCure, Inc., a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, announced that the clinical utility of the PROGENSA(R) PCA3 test, developed and commercialized by its partner Gen-Probe, was confirmed in two large worldwide studies, conducted in a subset of patients in GlaxoSmithKline's REDUCE trial of dutasteride. The results demonstrate that PCA3 can help determine whether men suspected of having prostate cancer should undergo a repeat biopsy and can predict the risk of having an aggressive cancer.
› Verified 9 days ago
Reagan L. Turner-bell, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
Sherri Ruerup, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 1319 Punahou St, Suite 801, Honolulu, HI 96826 Phone: 808-203-6580 Fax: 808-951-1637 | |
Dr. Erin F. Fallis, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: Tripler Army Medical Center 1 Jarrett White Rd, Honolulu, HI 96859 Phone: 888-683-2778 | |
Nami Ono, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1010 Pensacola St, Honolulu, HI 96814 Phone: 808-432-2000 | |
Mabel M. Sanqui, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1010 Pensacola St, Honolulu, HI 96814 Phone: 808-432-2000 | |
Dana C. Quealy, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1010 Pensacola St, Honolulu, HI 96814 Phone: 808-432-2000 |